Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles.
Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles.
复制标题
DOI：
10.1016/j.celrep.2017.06.008
复制
发表时间：
2017-06-27
期刊：
影响因子：
8.8
通讯作者：
Kwong LN
中科院分区：
文献类型：
--
作者：
Farshidfar F;Zheng S;Gingras MC;Newton Y;Shih J;Robertson AG;Hinoue T;Hoadley KA;Gibb EA;Roszik J;Covington KR;Wu CC;Shinbrot E;Stransky N;Hegde A;Yang JD;Reznik E;Sadeghi S;Pedamallu CS;Ojesina AI;Hess JM;Auman JT;Rhie SK;Bowlby R;Borad MJ;Cancer Genome Atlas Network;Zhu AX;Stuart JM;Sander C;Akbani R;Cherniack AD;Deshpande V;Mounajjed T;Foo WC;Torbenson MS;Kleiner DE;Laird PW;Wheeler DA;McRee AJ;Bathe OF;Andersen JB;Bardeesy N;Roberts LR;Kwong LN
胆管癌（CCA）是一种侵袭性的胆管恶性肿瘤，预后不良且治疗选择有限。在此，我们描述了癌症基因组图谱对一组以肝内胆管癌为主的病例进行的体细胞突变、RNA表达、拷贝数和DNA甲基化的综合分析，并提出了一种分子分类方案。我们确定了一种富含IDH突变的亚型，其具有独特的分子特征，包括染色质修饰因子表达较低、线粒体基因表达升高以及线粒体DNA拷贝数增加。利用多平台数据，我们观察到ARID1A在IDH突变亚型中表现出DNA高甲基化且表达降低。更广泛地说，我们发现IDH突变与具有与胆管癌分层的分子特征的肝脏肿瘤的组织学谱扩大有关。我们的研究揭示了对胆管癌分子发病机制和异质性的见解，并提供了具有潜在治疗意义的分类信息。
Cholangiocarcinoma (CCA) is an aggressive malignancy of the bile ducts, with poor prognosis and limited treatment options. Here, we describe the integrated analysis of somatic mutations, RNA expression, copy number, and DNA methylation by The Cancer Genome Atlas, of a set of predominantly intrahepatic CCA cases, and propose a molecular classification scheme. We identified an IDH-mutant enriched subtype with distinct molecular features including low expression of chromatin modifiers, elevated expression of mitochondrial genes, and increased mitochondrial DNA copy number. Leveraging the multi-platform data, we observed that ARID1A exhibited DNA hypermethylation and decreased expression in the IDH-mutant subtype. More broadly, we found that IDH mutations are associated with an expanded histological spectrum of liver tumors with molecular features that stratify with CCA. Our studies reveal insights into the molecular pathogenesis and heterogeneity of cholangiocarcinoma and provide classification information of potential therapeutic significance.
影响因子：
8.8
作者：
Farshidfar F;Zheng S;Gingras MC;Newton Y;Shih J;Robertson AG;Hinoue T;Hoadley KA;Gibb EA;Roszik J;Covington KR;Wu CC;Shinbrot E;Stransky N;Hegde A;Yang JD;Reznik E;Sadeghi S;Pedamallu CS;Ojesina AI;Hess JM;Auman JT;Rhie SK;Bowlby R;Borad MJ;Cancer Genome Atlas Network;Zhu AX;Stuart JM;Sander C;Akbani R;Cherniack AD;Deshpande V;Mounajjed T;Foo WC;Torbenson MS;Kleiner DE;Laird PW;Wheeler DA;McRee AJ;Bathe OF;Andersen JB;Bardeesy N;Roberts LR;Kwong LN
通讯作者：
Kwong LN